Health:Further 110 - Rich vs. Poor Lifespans, Trump’s Healthcare Shake-Up, and AI Diagnosing Your Health
Jan 4, 2025
The discussion kicks off with a look at the stock market's surprising strength amidst a struggling healthcare sector. Issues like Medicare Advantage and costly pharmacy options take center stage, highlighting the financial strain on providers. The hosts delve into the shocking reality of wealth disparities affecting lifespan, revealing that money can indeed buy health—but only to a point. Over in exciting tech, AI is stepping up as a diagnostic tool, using facial analysis to gain insights into patients' health, particularly the elderly.
AI Snips
Chapters
Transcript
Episode notes
Holiday Hiccups and Dog-Sitting
- Marcus recounts a pleasant holiday in the Dolomites, cut short by his wife's illness.
- He also discusses dog-sitting a smart Australian Shepherd.
Healthcare vs. Stock Market
- The stock market performed remarkably well over the past two years, outpacing healthcare stocks.
- This makes it harder for healthcare investments to outperform the market.
2024 Healthcare Stock Impacts
- Several factors impacted healthcare stocks in 2024, including concerns about Medicare Advantage, inflation, and the CVS situation.
- The murder of Brian Thompson and subsequent public sentiment also negatively affected payer stocks.